NCT01465529 A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT01460849 Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers Status WITHDRAWN Phase N/A
NCT01460836 Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis Status COMPLETED Phase N/A
NCT01455675 Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients Status COMPLETED Phase PHASE3
NCT01429259 Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children Status COMPLETED Phase PHASE4
NCT01427712 Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Status COMPLETED Phase N/A
NCT01426256 Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) Status COMPLETED Phase PHASE3
NCT01404234 Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways Status COMPLETED Phase PHASE3
NCT01401439 Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis Status COMPLETED Phase N/A
NCT01400750 Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT01377792 Study of Long-term Treatment With Hypertonic Saline in Patients With Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT01375049 Aztreonam Lysine for Pseudomonas Infection Eradication Study Status COMPLETED Phase PHASE2
NCT01375036 Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients Status COMPLETED Phase N/A
NCT01355796 Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2